Australia · New Zealand · Asia-Pacific
Connecting global pharmaceutical innovationwith patients across Asia-Pacific.
Vitalis Therapeutics partners with global pharmaceutical companies to bring innovative and essential medicines to market. We provide end-to-end regulatory, market access and commercialisation expertise — from development and registration through to launch, market growth and ongoing supply.
Derived from the Latin word for “life,” Vitalis is dedicated to delivering innovative, life-enhancing therapies to patients across Australia, New Zealand and Asia.
We specialise in medicines initiated by specialist clinicians — spanning generics, biosimilars and novel therapies — supported by deep expertise in hospital and specialist-driven markets.
Commercial success starts well before launch.
Regulatory, access, clinical, commercial and supply expertise — supporting medicines throughout their lifecycle.
Outcomes are driven by expertise and stakeholder engagement, not the size of the salesforce.
Our approachWhat we do
Therapeutic focus
Hospital and specialist medicines.
Oncology and haematology
Rare disease
Specialist hospital medicines
Biosimilars and biologics
Differentiated formulations
Selected advanced therapies
ANZ & Asia-Pacific
Developing a medicine for ANZ or APAC?
Talk to us about a market-entry strategy built around your asset.
Partner with Vitalis